Relugolix Combination Tablet Franchise in Ahmedabad

Gynaecology Medicine Supplier in Mumbai

Hormonal Therapy Tablet Distributor in Delhi

Women Health Pharma Franchise in Bangalore

Relugolix Combination Tablet Stockist in Hyderabad
Gynaecology Medicine Manufacturer & Exporter in Chandigarh

Home/Products /relugolix-40mg-estradiol-1mg-norethindrone-0-5mg-tablet

Ezendiol RN Tablet

Composition : Relugolix (40mg) + Estradiol (1mg) + Norethindrone (0.5mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 2x5

Price : ₹0/-

Ezendiol RN Tablet contains Relugolix 40mg + Estradiol 1mg + Norethindrone 0.5mg, a combination therapy used in the management of hormone-dependent gynaecological conditions, including uterine fibroids and related menstrual disorders.

Relugolix acts as a gonadotropin-releasing hormone (GnRH) antagonist, reducing estrogen production, while Estradiol and Norethindrone provide hormonal balance to minimize estrogen-deficiency symptoms and improve tolerability.

This balanced formulation helps in controlling heavy menstrual bleeding, pelvic discomfort, and hormone-related symptoms, allowing effective long-term management under medical supervision.

Ezendiol RN Tablet is valued for its targeted hormonal control, improved patient comfort, and consistent clinical performance, making it a reliable option in advanced gynaecology and women’s health treatment protocols.

Read More

About the Product

Ezendiol RN Tablet contains Relugolix 40mg + Estradiol 1mg + Norethindrone 0.5mg, a combination therapy used in the management of hormone-dependent gynaecological conditions, including uterine fibroids and related menstrual disorders.

Relugolix acts as a gonadotropin-releasing hormone (GnRH) antagonist, reducing estrogen production, while Estradiol and Norethindrone provide hormonal balance to minimize estrogen-deficiency symptoms and improve tolerability.

This balanced formulation helps in controlling heavy menstrual bleeding, pelvic discomfort, and hormone-related symptoms, allowing effective long-term management under medical supervision.

Ezendiol RN Tablet is valued for its targeted hormonal control, improved patient comfort, and consistent clinical performance, making it a reliable option in advanced gynaecology and women’s health treatment protocols.

Common side effects may include headache, hot flashes, nausea, fatigue, irregular menstrual bleeding, breast tenderness, and mood changes. Some patients may experience blood pressure changes or mild weight gain. Any unusual bleeding, severe headache, or signs of thromboembolic events should be reported to a doctor immediately.

Ezendiol RN Tablet is indicated for the management of moderate to severe symptoms associated with uterine fibroids and other estrogen-dependent gynecological conditions in adult women. It helps reduce heavy menstrual bleeding and related symptoms while supporting hormonal balance.

Ezendiol RN Tablet should be taken strictly as prescribed by a healthcare professional. It is not recommended during pregnancy or breastfeeding. Regular monitoring may be required for bone mineral density, blood pressure, and lipid profile during long-term use.

Store Ezendiol RN Tablet in a cool, dry place below 25 °C, protected from moisture and direct sunlight. Keep out of reach of children and do not use beyond the expiry date printed on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation